Term ends Aug 9, 2039 · Medium confidence
20-year base term ends Aug 9, 2039
Why Medium: A parent in the chain could not be resolved.
Aug 9, 2019
Aug 9, 2039
Dec 13, 2022
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 9, 2019, when application PCT/US2019/045985, the earliest non-provisional in its chain, was filed (this one was filed Sep 10, 2021); a parent in its chain could not be resolved (the next row) | Aug 9, 2039 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,466,256) | resolves to Aug 9, 2039, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Aug 9, 2039 | Medium confidence |
This family
| Application PCT/US2019/045985 | PCT application no patent term | no patent term |
| US 12,215,355 | In force Jan 2042 | Jan 2042 |
| US 11,466,256 | In force Aug 2039 | Aug 2039 |
| US 11,525,120 | this patent Aug 2039 | Aug 2039 |
| US 11,999,971 | In force Aug 2039 | Aug 2039 |
| Application 18/055,327 | Abandoned not computed | not computed |
| Application 19/000,973 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 20, 2022 Reel 60567, frame 110 | Pagliuca, Felicia J.; Harb, George; Ye, Lillian | Semma Therapeutics, Inc. | Assignment of Assignor's Interest |
| Jul 20, 2022 Reel 60567, frame 238 | Semma Therapeutics, Inc. | Vertex Pharmaceuticals Incorporated | Merger |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 11,466,256, ends no earlier than this term, so it caps nothing.